- TOP
- Company Information
- Corporate Profile
Corporate Profile
- Corporate name
- YUKI GOSEI KOGYO CO., LTD.
- Offices
- Head Office, Business DivisionⅡ, Tokyo Research Laboratory, Joban Factory, Düsseldorf Office
- Business Fields
- ・Pharmaceuticals
・Food additives
・Industrial chemicals
- Capital
- 3,471 million yen (total number of issued shares: 21,974,000 shares)
Listed on the Tokyo Stock Exchange, Standard Market
- Executives
(as of June 24, 2026) -
President & CEO
Business Sector
Seiichiro MatsumotoDirector & Managing Executive Officer, Research & Development Sector, Manufacturing Sector
Masahiro KusanoDirector & Senior Executive Officer, Business Administration Sector
Hiromi IshikawaDirector, Audit & Supervisory Committee Member
Naotake SutoDirector, Audit & Supervisory Committee Member
Norito OhoriDirector, Audit & Supervisory Committee Member
Eriko ItakuraSenior Executive Officer, General Manager, Business DivisionⅠ
Masao MatsukawaExecutive Officer, General Manager, Quality Assurance Division
Hiroshi NakamuraExecutive Officer, General Manager, Quality Assurance Division
Tetsuji NodaExecutive Officer, General Manager, General Affairs & Human Resources Division
Masaki Nakajima
- Number of employees
(as of March 31, 2026) - 296 (excluding loan, part-time and temporary employees)
- Major banks
- MUFG Bank, Ltd., Joyo Bank, Mitsubishi UFJ Trust and Banking Corporation, Mizuho Bank, Ltd.
- Affiliated company
- Yuki Techno Service Co., Ltd.(Address:10-4, Nihonbashi-Ningyocho 3-chome, Chuo-ku, Tokyo 103-0013, Representative:Masahiro Kusano, President)
Organizational Chart
History
1947
Yuki Gosei Kogyo Kabushikigaisha (Yuki Gosei Kogyo Co., Ltd.) was established to produce flavors for tobacco
-
1948
Acquired Maeno Plant (later renamed“Maeno Office”) -
1952
Started manufacture of glycine, isoniazid and nicotinic acid amide -
1958
Started manufacture of beta-alanine and pinkmine -
1960
Started manufacture of 2-vinylpyridine -
1961
Started manufacture of glycine and beta-alanine using a new manufacturing method -
1962
The company’s name in Japanese changed from“Yuki Gosei Kogyo Kabushikigaisha”to“Yuki Gosei Yakuhin Kogyo Kabushikigaisha”
The Head Office moved to Takara-cho, Chuo-ku
Listed on the Second Section of the Tokyo Stock Exchange -
1963
Started manufacture of triacetin -
1964
Started operation of Joban Plant
Started manufacture of flavors for Peace cigarettes -
1965
Started manufacture of protamine sulfate and flavors for mf cigarettes -
1966
Started manufacture of leucic acid and flavors for Hi-lite cigarettes -
1967
Started manufacture of nicotinic acid amide using a new manufacturing method
Started manufacture of 3-cyanopyridine -
1968
Started manufacture of 8-hydroxyquinoline and flavors for Seven Stars cigarettes -
1969
Started manufacture of amino acid sugar (Yukisu) -
1970
Started manufacture of flavors for Cherry cigarettes -
1971
Started manufacture of glycine at new facilities -
1972
Started manufacture of nicotinic acid amide at new facilities
Tokyo Laboratory completed -
1973
Started manufacture of iminodiacetic acid -
1975
Started manufacture of intermediates for agricultural chemicals and picolinic acid -
1976
Started manufacture of CP essence -
1977
Started manufacture of 3-aminopyridine -
1978
Started manufacture of DNA
Activated sludge treatment facilities completed at Joban Plant -
1982
Test plant facilities newly installed at Tokyo Laboratory -
1983
Facilities for manufacturing flavors and materials for tobacco newly installed at Joban Plant -
1984
Multi-purpose manufacturing facilities newly installed at Joban Plant -
1985
Started manufacture of silicone-related products -
1986
Started manufacture of 4-aminopyridine and isonicotinic acid -
1990
Drug intermediate-purification facilities newly installed at Joban Plant
Capital increased to 2,550 million yen -
1991
The Head Office moved to Hirakawa-cho, Chiyoda-ku
Manufacturing facilities for silicon and grignard reagents newly installed at Joban Plant -
1992
Multi-purpose, small-amount manufacturing facilities newly installed at Joban Plant -
1995
The Head Office moved to the current location
A laboratory (Technological Development Center) newly established at Joban Plant
DNA manufacturing facilities newly installed at Joban Plant -
1996
The 2-vinylpyridine manufacturing facilities moved from Tokyo Laboratory to Joban Plant
Joban Plant certified for ISO 9002.
Manufacturing facilities dedicated to silicon- and grignard-related products newly installed at Joban Plant
Capital increased to 3,471 million yen
Started manufacture of trifluorothymidine -
1998
The Head Office, Osaka Sales Office, Joban Plant and Tokyo Laboratory certified for ISO 9001
Investigational drug testing research facilities newly installed at Joban Plant -
1999
Certified for ISO 14001 -
2001
Started manufacture of Fudosteine “YUKI”
Yuki Engineering Co., Ltd., an affiliated company, renamed “Yuki Techno Service Co., Ltd”
Pharmaceutical manufacturing facilities newly installed at Joban Plant -
2003
Selected as loanable stock
Quality Control Building newly completed at Joban Plant. -
2004
Listed on the First Section of the Tokyo Stock Exchange market
Started operation of the enterprise resource planning system -
2006
Dusseldorf Office established as an overseas office -
2007
LNG conversion facilities newly established -
2012
Started manufacture of active pharmaceutical ingredients for generics -
2014
Cogeneration system introduced -
2018
APIs and pharmaceutical intermediates manufacturing facilities installed at Joban Plant -
2021
Certified for FSSC 22000 -
2022
Changed to the Standard Market of the Tokyo Stock Exchange -
2025
Additonal glycine production facilies installed at Joban Factory



